- Home
- FCF vs BHVN Comparison
FCF vs BHVN Comparison
Compare FCF & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCF
- BHVN
- Stock Information
- Founded
- FCF 1934
- BHVN 2013
- Country
- FCF United States
- BHVN United States
- Employees
- FCF N/A
- BHVN N/A
- Industry
- FCF Major Banks
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- FCF Finance
- BHVN Health Care
- Exchange
- FCF Nasdaq
- BHVN Nasdaq
- Market Cap
- FCF 1.6B
- BHVN 1.9B
- IPO Year
- FCF N/A
- BHVN 2017
- Fundamental
- Price
- FCF $14.55
- BHVN $20.37
- Analyst Decision
- FCF Buy
- BHVN Strong Buy
- Analyst Count
- FCF 7
- BHVN 14
- Target Price
- FCF $19.36
- BHVN $63.15
- AVG Volume (30 Days)
- FCF 1.3M
- BHVN 1.7M
- Earning Date
- FCF 04-29-2025
- BHVN 05-08-2025
- Dividend Yield
- FCF 3.57%
- BHVN N/A
- EPS Growth
- FCF N/A
- BHVN N/A
- EPS
- FCF 1.39
- BHVN N/A
- Revenue
- FCF $448,502,000.00
- BHVN N/A
- Revenue This Year
- FCF $11.80
- BHVN N/A
- Revenue Next Year
- FCF $9.58
- BHVN $65.26
- P/E Ratio
- FCF $10.47
- BHVN N/A
- Revenue Growth
- FCF N/A
- BHVN N/A
- 52 Week Low
- FCF $12.41
- BHVN $15.79
- 52 Week High
- FCF $19.96
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- FCF 41.64
- BHVN 39.78
- Support Level
- FCF $13.77
- BHVN $15.79
- Resistance Level
- FCF $15.23
- BHVN $19.30
- Average True Range (ATR)
- FCF 0.55
- BHVN 2.20
- MACD
- FCF 0.00
- BHVN 0.26
- Stochastic Oscillator
- FCF 48.33
- BHVN 42.84
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.